BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28314633)

  • 1. Challenges and Outlooks in Multi-drug Resistant Tuberculosis.
    Caminero Luna JA
    Arch Bronconeumol; 2017 Aug; 53(8):417-418. PubMed ID: 28314633
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug-resistant tuberculosis plagues India.
    Sibbald B
    CMAJ; 2016 Mar; 188(5):322-324. PubMed ID: 26883311
    [No Abstract]   [Full Text] [Related]  

  • 3. Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016.
    Mustazzolu A; Borroni E; Cirillo DM; Giannoni F; Iacobino A; ; Fattorini L
    Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29724919
    [No Abstract]   [Full Text] [Related]  

  • 4. Multidrug resistant tuberculosis.
    Amdekar YK
    Indian Pediatr; 1998 Aug; 35(8):715-8. PubMed ID: 10216564
    [No Abstract]   [Full Text] [Related]  

  • 5. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA; Voloshina EP; Adamovich NV; Maslakova MG; Terekhova ND
    Probl Tuberk Bolezn Legk; 2005; (12):37-9. PubMed ID: 16496762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is new in the WHO consolidated guidelines on drug-resistant tuberculosis treatment?
    Sharma SK; Dheda K
    Indian J Med Res; 2019 Mar; 149(3):309-312. PubMed ID: 31249191
    [No Abstract]   [Full Text] [Related]  

  • 8. Multidrug-resistant/extensively drug-resistant tuberculosis in Greece: predominance of Mycobacterium tuberculosis genotypes endemic in the Former Soviet Union countries.
    Ioannidis P; van Soolingen D; Mokrousov I; Papaventsis D; Karabela S; Konstantinidou E; Marinou I; Nikolaou S; Kanavaki S; Mantadakis E; Samonis G; Anthony R; Vogiatzakis E
    Clin Microbiol Infect; 2017 Dec; 23(12):1002-1004. PubMed ID: 28698038
    [No Abstract]   [Full Text] [Related]  

  • 9. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
    Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
    Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternatives to INH chemoprophylaxis.
    Sane SV; Sane NS; Thakker SV
    Indian Pediatr; 1995 Aug; 32(8):935-7. PubMed ID: 8635847
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advantages and disadvantages of longer and shorter chemotherapy regimens for multi-drug or rifampicin-resistant tuberculosis].
    Li Q; Li L
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 May; 42(5):333-338. PubMed ID: 31137109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and epidemiological characteristics of patients with drug-resistant tuberculosis].
    Okulovskaia SS; Gurevich GL; Bogomazova AV
    Probl Tuberk; 1999; (6):6-8. PubMed ID: 10715945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment duration for patients with drug-resistant tuberculosis, United States.
    Winston CA; Mitruka K
    Emerg Infect Dis; 2012 Jul; 18(7):1201-2. PubMed ID: 22709909
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
    Ramos E; Fissette K; de Rijk P; Palomino JC; Martin A
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):110-3. PubMed ID: 22236855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiresistant tuberculosis in Brazil: history and control].
    Dalcolmo MP; Andrade MK; Picon PD
    Rev Saude Publica; 2007 Sep; 41 Suppl 1():34-42. PubMed ID: 18038089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.